DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Reversal of General Anesthesia With Methylphenidate

Information source: Massachusetts General Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Post Operative Cognitive Dysfunction; Emergence From Anesthesia

Intervention: Methylphenidate (Drug)

Phase: Phase 1/Phase 2

Status: Enrolling by invitation

Sponsored by: Massachusetts General Hospital

Summary

The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure).

Clinical Details

Official title: Reversal of Propofol-Induced General Anesthesia With Intravenous Methylphenidate

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Primary outcome: Number of Participants with Adverse Events as a Measure of Safety and Tolerability

Secondary outcome: Time to emergence from general anesthesia

Eligibility

Minimum age: 18 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age 18-75 years

- American Society of Anesthesiologists classification 1 or 2

- Scheduled to undergo a pancreaticoduodenectomy or distal pancreatectomy at

Massachusetts General Hospital Exclusion Criteria:

- American Society of Anesthesiologists physical status classification of 3 or beyond.

Locations and Contacts

Massachusetts General Hospital, Boston, Massachusetts 02114, United States
Additional Information

Starting date: November 2014
Last updated: April 8, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017